A new series of 1,3,4-thiadiazole derivatives containing oxadiazole (3a – 3e), thiadiazole (4a – 4e), and triazole (5a – 5e) moieties have been prepared using 2-(5-phenyl-1,3,4-thiadiazol-2-ylamino)acetic acid (2) as intermediate. The structures of newly synthesized compounds are confirmed by 1H NMR, 13C NMR, and FT-IR spectroscopy, LC/MS mass spectrometry, and elemental analysis data. Furthermore, all the newly synthesized compounds were also tested for their in vitro antibacterial activity against selected human pathogens viz. Escherichia coli, Salmonella typhimurium, Legionella monocytogenes, Klebsiella pneumonia, Salmonella typhi, Staphylococcus aureus and Bacillus subtilis and antifungal activity against Candida albicans, Streptococcus pyogenes and Fusarium solani strains. The preliminary results revealed that certain compounds exhibited promising antimicrobial activities against the test microorganisms. Nine of the total of 15 compounds exhibited excellent antibacterial activity and antifungal activity.
Similar content being viewed by others
References
S. Maddila and S. B. Jonnalagadda, Arch. Pharm. Chem. Life Sci., 345, 163–168 (2012).
S. Maddila and S. B. Jonnalagadda, Lett. Drug Design Disc., 9 (2012) [in press].
F. A. Ashour, N. S. Habib, M. El-Taibbi, et al., Farmaco, 45, 1341–1349 (1990).
N. S. Habib, R. Soliman, F. A. Ashour and M. El-Taiebi, Pharmazie, 52, 844–847 (1997).
S. M. Badr and R. M. Barwa, Bioorg. Med. Chem., 19, 4506–4512 (2011).
S. A. El-Dine, F. H. Jawad and N. F. Mahmoud, Pharmazie, 32, 101–103 (1984).
A. Vedani and E. F. Jr. Meyer, J. Pharm. Sci., 73, 352–358 (1984).
A. F. Atta, O. O. Farahat, A. Z. Ahmed and M. G. Marei, Molecules, 16, 5496–5506 (2011).
P. Zoumpoulakis, Ch. Camoutsis, G. Pairas, et al., Bioorg. Med. Chem., 20, 1569–1583 (2012).
J. Matysiak and Z. Malinski, Bioorg. Khim., 33, 640–647 (2007) [Russ. J. Bioorg. Chem., 33, 594 (2012)].
F. Liu, X. Q. Luo, B. A. Song, et al., Bioorg. Med. Chem., 16, 3632–3640 (2008).
N. T. Klip, G. Capan, A. Gursoy, et al., J. Enzyme. Inhib. Med. Chem., 25, 126–131 (2010).
K. G. Andanappa, N. N. Malleshappa and K. V. Rajshekhar, Bioorg. Med. Chem., 12, 5651–5659 (2004).
A. Foroumadi, F. Soltani, R. Jabini, et. al., Arch. Pharm. Res., 27, 502–506 (2004).
F. P. Invidiata, D. Simoni, P. Scintu and N. Pinna, Farmaco II, 51, 659–664 (1996).
N. A. Al-Masoudi, Y. A. Al-Soud and W. A. Al-Masoudi, Nucleosides, Nucleotides, Nucleic Acids, 23, 1739–1749 (2004).
Z. Chen, W. Xu, L. Liu, S., et al., Molecules, 15, 9046–9056 (2010).
M. H. Shih and F. Y. Ke, Bioorg. Med. Chem., 12, 4633–4643 (2004).
I. Khan, S. Ali, S. Hameed, N. H. Rama, et al., Eur. J. Med. Chem., 45, 5200–5207 (2010).
K. Miyamoto, R. Koshiura, M. Mori, et al., Chem. Pharm. Bull., 33, 5126–5129 (1985).
M. N. Noolvi, H. M. Patel, N. Singh, et al., Eur. J. Med. Chem., 46, 4411–4418 (2011).
Z. Luo, B. Chen, S. He, et al., Bioorg. Med. Chem. Lett., 22, 3191–3193 (2012).
A. K. Shakya, P. Mishra, G. K. Patnaik, et al., Arch. Pharm. Res., 21, 753–758 (1998).
N. Chidananda, B. Poojary, V. Sumangala, et al., Eur. J. Med. Chem., 51, 124–136 (2012).
A. Gupta, P. Mishra, S. N. Pandeya, et al., Eur. J. Med. Chem., 44, 1100–1105 (2009).
X. Q. Deng, Z. Q. Dong, M. X. Song, et al., Arch. Pharm (Weinheim) (2012); doi: 10.1002/ardp.201100326.
Performance Standards for Antimicrobial Susceptibility Test, 9th Intern. Suppl. (National Committee for Clinical Laboratory Standards (NCCLS), Wayne, PA, 1999).
Acknowledgements
The authors acknowledge financial support from the University of KwaZulu-Natal in the form of laboratory facilities and postdoctoral bursary to one of the authors (S. M.).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maddila, S., Jonnalagadda, S.B. Synthesis and antimicrobial activity of new 1,3,4-thiadiazoles containing oxadiazole, thiadiazole and triazole nuclei. Pharm Chem J 46, 661–666 (2013). https://doi.org/10.1007/s11094-013-0865-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-013-0865-x